CDT Highlights Sarborg's Application of Quantum Computing to Solid-Form Development
CDT Equity Stock Gets A Boost On SarborgQ Development News
CDT Notes Strategic Investment into Sarborg and Expansion into Quantum Computing
CDT Equity Announces Debt Update and New Loan Facility
CDT Equity Inc. Announces Receipt of Nasdaq Deficiency Letter
CDT Environmental Technology Investment Holdings Limited Announces Share Consolidation
CDT Announces Canadian Patent for AZD5904 in Male Infertility
CDT Environmental Technology Files 2025 Annual Report on Form 20-F
CDT Notes Sarborg Filing of Substance of Matter Patent in Cystic Fibrosis Market
CDT Advances AZD5904 into Global Patent Phase and Initiates Partnering Discussions
CDT Expands Multi-Pathway Value Creation Strategy Across Pharma, IP and AI-Driven Discovery
What's Going On With CDT Equity Shares On Monday?
Rosen Law Firm Encourages CDT Environmental Technology Investment Holdings Ltd. Investors to Inquire About Securities Class Action Investigation – CDTG
Rosen Law Firm Encourages CDT Environmental Technology Investment Holdings Ltd. Investors to Inquire About Securities Class Action Investigation – CDTG
CDT Notes Sarborg Publication of PRISM Framework Expanding AI
CDT Equity Inc. (NASDAQ:CDT) Sees Significant Decrease in Short Interest
CDT Equity Expands Tapinarof Intellectual Property Portfolio with Two New Patent Filings
CDT Equity Inc. Announces Reverse Stock Split
CDT Identifies Rare Disease Opportunities Through Sarborg Signature Analysis, Advancing Out-Licensing Strategy
CDT Equity Stockholders Approve All Proposals at Special Meeting, Positioning the Company for Next Phase of Growth
CDT Equity Inc. (NASDAQ:CDT) Short Interest Update
CDT Notes Sarborg Expansion into Rare Disease Signature Intelligence
CDT Equity Notes Sarborg Filing of U.S. Provisional Patent Application for AI Signature Agent
CDT Positions for Transformational Growth
CDT Equity Notes Sarborg Expansion into Bacteria and Agrochemicals
CDT Acquires Strategic Stake in Sarborg to Transform its AI-Driven Asset Strategy
CDT Environmental Technology Announces Private Placement of Common Stock
CDT Environmental Technology Announces Private Placement of Common Stock
CDT Engages NJS Foresight Bio-Advisory to Support Solid-Form Out-Licensing Strategy
CDT Environmental Technology Reports 2025 Unaudited Interim Financial Results and Provides Business Updates
CDT Environmental Technology Reports 2025 Unaudited Interim Financial Results and Provides Business Updates
CDT Environmental Technology Announces Results of Annual General Meeting
CDT Environmental Technology Announces Results of Annual General Meeting
CDT Environmental Technology Announces New Strategic Growth Initiatives, Enters Clean Energy Market with Waste-to-Hydrogen Technology
CDT Environmental Technology Announces New Strategic Growth Initiatives, Enters Clean Energy Market with Waste-to-Hydrogen Technology
CDT Equity Increases Bitcoin Holding
CDT Equity Inc. Announces Reverse Stock Split
CDT Environmental Technology Announces Results of Extraordinary General Meeting
CDT Environmental Technology Announces Results of Extraordinary General Meeting
CDT Executes Cryptocurrency Treasury Reserve Strategy
CDT Equity Identifies New Biological Target Validating AI-Driven Repurposing Strategy
Conduit Pharmaceuticals Files New Patents Following AI-Driven Combination Discoveries
CDT Environmental Technology Announces Receipt of Notification Letter from Nasdaq
Conduit Pharmaceuticals Enters Joint Development Agreement with Manoira to Advance AZD1656 and AZD5658 in Animal Health
Conduit Pharmaceuticals Inc. Listing on Nasdaq Capital Market
Conduit Pharmaceuticals Inc. Regains Nasdaq Compliance
Conduit Pharmaceuticals Inc. Announces Reverse Stock Split
CDT Environmental Technology Files Annual Report on Form 20-F
Conduit Pharmaceuticals Receives Further Patent Approval For Its Lead Asset Targeting Autoimmune Diseases